34D.F 104.1 (-0.72%)
IT0003492391• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. 34D.F

Diasorin (34D.F) Competitor Comparison

We are evaluating the key criteria listed to compare Diasorin (34D.F) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 56

Dividend yield

0 / 8

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Performance 10 years - 34D.F ranking 0 / 58

These are the competitors of Diasorin in the industry Diagnostics & Research ranked by performance 10 years
1. Lantheus Holdings LNTH
1.81K
2. Heska HSKA
1.65K
3. Medpace Holdings MEDP
1.17K
4. RadNet RDNT
693.48
5. IDEXX Laboratories IDXX
670.28
6. DexCom DXCM
613.81
7. Natera NTRA
580
8. Mettler-Toledo MTD
472.42
9. Danaher DHR
447.01
10. Icon ICLR
442.1
11. Thermo Fisher Scientific TMO
437.63
12. IQVIA Holdings IQV
330.03
13. CareDx CDNA
316.32
14. Agilent Technologies A
272.74
15. Twist Bioscience TWST
261
16. Waters WAT
260.6
17. PerkinElmer PKI
247.07
18. Charles River Laboratories CRL
223.42
19. Exact Sciences EXAS
202.61
20. NeoGenomics NEO
171.2
21. Laboratory Corp of America Holdings LH
155.59
22. Quest Diagnostics DGX
155.16
23. Fulgent Genetics FLGT
114.55
24. Syneos Health SYNH
113.83
25. Qiagen QGEN
89.93
26. Meridian Bioscience VIVO
60.69
27. National Research NRC
36.27
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Neogen NEOG
-4.5
30. Illumina ILMN
-9.31
31. Bioventus BVS
-14.24
32. Guardant Health GH
-22.95
33. Inotiv NOTV
-24.23
34. Olink Holding OLK
-26.82
35. Myriad Genetics MYGN
-33.19
36. Anixa Biosciences ANIX
-36.63
37. Sotera Health SHC
-40.74
38. Sera Prognostics SERA
-48.9
39. Pacific Biosciences of California PACB
-63.4
40. Global Cord Blood CO
-66.57
41. DarioHealth DRIO
-75.47
42. Enzo Biochem ENZ
-76.04
43. MaxCyte MXCT
-77.81
44. Co-Diagnostics CODX
-78.67
45. Personalis PSNL
-79.36
46. Exagen XGN
-82.86
47. bioAffinity Technologies BIAF
-83.21
48. MDxHealth MDXH
-83.54
49. Psychemedics PMD
-83.64
50. Biodesix BDSX
-88.15
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-95.74
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-98.05
56. Interpace Biosciences IDXG
-98.4
57. Organovo Holdings ONVO
-99.26
58. Precipio PRPO
-99.75
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.